P. Anné

P. Anné, R. Axelrod, W. Keane, 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

LINICAL INVESTIGATION Head and Neck A PHASE II TRIAL OF SUBCUTANEOUS AMIFOSTINE AND RADIATION THERAPY IN PATIENTS WITH HEAD-AND-NECK CANCER

W. Curran, D. Brizel, D. Rosenthal, 2007 .

Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report

A. Dicker, T. Showalter, P. Anné, 2008, Journal of medical case reports.

Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development.

D. Eschelman, P. Anné, Takami Sato, 2011, AJR. American journal of roentgenology.

Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.

D. Eschelman, P. Anné, Takami Sato, 2011, Journal of vascular and interventional radiology : JVIR.

Radiation Therapy for Melanoma

W. Shi, P. Anné, B. Simone, 2018 .

Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).

J. Bourhis, D. Brizel, M. Turner, 2004, International journal of radiation oncology, biology, physics.

Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature

C. Yeo, V. Bar-ad, M. Hurwitz, 2015, Case reports in pancreatic cancer.

Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

B. Erickson, C. Willett, T. Rich, 2012, OncoTargets and therapy.

Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two‐institution report

W. Scott, A. Berger, E. Mitchell, 2010, Journal of surgical oncology.

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.

B. Erickson, A. Rashid, C. Willett, 2015, International journal of radiation oncology, biology, physics.

Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

B. Erickson, A. Rashid, C. Willett, 2012, International journal of radiation oncology, biology, physics.

OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLYADVANCED RECTAL CANCER

B. Erickson, A. Rashid, C. Willett, 2012 .

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

J. Ajani, J. Donohue, J. Bradley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation Therapy for Locally Recurrent Breast Cancer

N. Simone, P. Anné, C. Champ, 2012, International journal of breast cancer.

Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.

R. Jagsi, W. Woodward, H. Kuerer, 2019, JAMA oncology.

Conditional Survival Probabilities for Patients With Resected Pancreatic Adenocarcinoma

T. Showalter, Y. Lawrence, V. Bar-ad, 2014, American journal of clinical oncology.

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school.

Nicholas G Zaorsky, A. Dicker, T. Showalter, 2012, International journal of radiation oncology, biology, physics.

Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study.

Nicholas G Zaorsky, A. Dicker, T. Showalter, 2013, International journal of radiation oncology, biology, physics.

Cholangiocarcinoma: The Impact of Tumor Location and Treatment Strategy on Outcome

David E. Stein, D. Heron, F. Waterman, 2003, American journal of clinical oncology.

Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold.

N. Simone, A. Dicker, P. Anné, 2015, Practical radiation oncology.

Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial.

N. Simone, P. Anné, Joshua Siglin, 2015, Practical radiation oncology.

Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer

A. Dicker, P. Anné, R. Axelrod, 2016, American journal of clinical oncology.

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.

J. Bendell, T. Hong, S. Jabbour, 2015, International journal of radiation oncology, biology, physics.

Impact of Her-2 Neu Overexpression on Outcome of Elderly Women Treated With Wide Local Excision and Breast Irradiation for Early Stage Breast Cancer: An Exploratory Analysis

W. Curran, Igor M Poltinnikov, Y. Tymofyeyev, 2006, American journal of clinical oncology.

Long-term survival outcome of E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged esophageal adenocarcinoma.

P. Catalano, A. Benson, L. Kleinberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus

A. Benson, L. Kleinberg, P. Anné, 2007 .

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design.

P. Catalano, A. Benson, L. Kleinberg, 2016, International journal of radiation oncology, biology, physics.

Racial disparity trends in clinical presentation and outcomes in colorectal cancer: Findings from an urban university hospital.

E. Mitchell, P. Anné, A. Topham, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation Therapy Use and Outcomes Among Older Women With ER-Positive and ER-Negative Stage I Breast Cancer

T. Showalter, V. Bar-ad, A. Wojcieszynski, 2014, American journal of clinical oncology.

Microsatellite instability predicts for tumor response in a prospective trial of preoperative 5-FU, CPT-11 and radiation for locally advanced rectal cancer

W. Curran, J. Palazzo, B. Boman, 2000 .

Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.

P. Anné, 2002, Seminars in oncology.

Reirradiation of head and neck cancer with high-dose-rate brachytherapy: a customizable intraluminal solution for postoperative treatment of tracheal mucosa recurrence.

Yan Yu, T. Showalter, Ying Xiao, 2011, Brachytherapy.

Brain Metastases in Patients with Gynecologic Cancers: A Single Institution Experience and Review of the Literature

N. Rosenblum, W. Shi, R. Schilder, 2016, Open journal of obstetrics and gynecology.

A phase II trial of preoperative paclitaxel, carboplatin, 5-FU and radiation in patients with resectable esophageal or gastric cancer (Ca)

W. Curran, E. Mitchell, P. Anné, 2004 .

The use of mixed-integer programming for inverse treatment planning with pre-defined field segments.

Ying Xiao, Greg Bednarz, M. Saiful Huq, 2001, Physics in medicine and biology.

Our Mission

R. Heiberger, G. Ainslie, J. Headd, 2006 .

Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy.

W. Curran, J. Palazzo, B. Boman, 2004, Anticancer research.

Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two‐institution report

W. Scott, A. Berger, E. Mitchell, 2010, Journal of surgical oncology.

Implementation and experimental results of 4D tumor tracking using robotic couch.

T. Podder, Y. Yu, Ivan Buzurovic, 2012, Medical physics.

Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

P. Anné, Sneha Alaparthi, Wilbur B. Bowne, 2024, World journal of oncology.

Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer.

B W Corn, W W Hauck, R K Valicenti, 1999, International journal of radiation oncology, biology, physics.